Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors

1. Paz-Ares, L.
2. Forster, M.
3. Boni, V.
4. Szyldergemajn, S.
5. Corral, J.
6. Turnbull, S.
7. Cubillo, A.
8. Teruel, C.F.
9. Calderero, I.L.
10. Siguero, M.
11. Bohan, P.
12. Calvo, E.